Results 201 to 210 of about 379,925 (396)
Preoperative Detection of Dual TERT Promoter Mutations in Thyroid Cancer: A Case Series
ABSTRACT Telomerase reverse transcriptase promoter (TERTp) mutations are associated with aggressive thyroid cancer and are most frequently found in anaplastic and poorly differentiated thyroid cancer. Pre‐operative thyroid nodule molecular testing can detect TERTp, denoting a high risk of malignancy and possible aggressive clinical features such as ...
Amir Harari +7 more
wiley +1 more source
ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
Prognosis of differentiated thyroid cancer in patients with Graves' disease: a meta-analysis. [PDF]
Zhang D +5 more
europepmc +1 more source
An Explainable AI Model for Predicting the Recurrence of Differentiated Thyroid Cancer [PDF]
Manzoor Ahmad, John J. Haddad
openalex +1 more source
Predictive value of SPECT/CT after radioiodine therapy in differentiated thyroid cancer [PDF]
Szabina Szujó +5 more
openalex +1 more source
Abstract Efforts to use transcriptomics for toxicity testing have classically relied on the assumption that chemicals consistently produce characteristic transcriptomic signatures that are reflective of their mechanism of action. However, the degree to which transcriptomic responses are conserved across different test methodologies has seldom been ...
Paul Béziers +10 more
wiley +1 more source
Effects of Lenvatinib treatment for advanced differentiated thyroid cancer on cortisol deficiency. [PDF]
Monti S +8 more
europepmc +1 more source

